Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Top Cited Papers
- 25 July 2005
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 109 (2) , 143-159
- https://doi.org/10.1042/cs20050025
Abstract
The endothelium is a complex organ with a multitude of properties essential for control of vascular functions. Dysfunction of the vascular endothelium is regarded as an important factor in the pathogenesis of diabetic micro- and macro-angiopathy. Endothelial dysfunction in Type I and 11 diabetes complicated by micro- or macro-albuminuria is generalized in that it affects many aspects of endothelial function and occurs not only in the kidney. The close linkage between micro-albuminuria and endothelial dysfunction in diabetes is an attractive explanation, for the fact that microalbuminuria is a risk marker for atherothrombosis. In Type I diabetes, endothelial dysfunction precedes and may cause diabetic microangiopathy, but it is not clear whether endothelial dysfunction is a feature of the diabetic state itself. In Type 11 diabetes, endothelial function is impaired from the onset of the disease and is strongly related to adverse outcomes. It is not clear whether impaired endothelial function is caused by hyperglycaemia or by other factors. Impaired endothelial function is closely associated with and may contribute to insulin resistance regardless of the presence of diabetes. Endothelial dysfunction in diabetes originates from three main sources. Hyperglycaemia and its immediate biochemical sequelae directly alter endothelial function or influence endothelial cell functioning indirectly by the synthesis of growth factors, cytokines and vasoactive agents in other cells. Finally, the components of the metabolic syndrome can impair endothelial function.Keywords
This publication has 192 references indexed in Scilit:
- Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertensionInternational Journal of Cardiology, 2005
- The Two Faces of Endothelial Nitric Oxide Synthase in the Pathophysiology of AtherosclerosisEndothelium, 2004
- α-Oxoaldehyde metabolism and diabetic complicationsBiochemical Society Transactions, 2003
- VEGF signalling: integration and multi-tasking in endothelial cell biologyBiochemical Society Transactions, 2003
- Maillard reaction products in tissue proteins: New products and new perspectivesAmino Acids, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- Glucose, VEGF-A, and Diabetic ComplicationsThe American Journal of Pathology, 2001
- Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κbFree Radical Biology & Medicine, 2000
- Diabetic dyslipidaemia and coronary heart diseaseCurrent Opinion in Lipidology, 1999
- A Prospective Study of Obesity and Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1990